Horizon Kinetics Asset Management LLC Viatris Inc Transaction History

Horizon Kinetics Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$8.72 - $11.56 $96,600 - $128,061	-11,078 Reduced 36.59%	19,198 $213,000
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $50,065 - $65,711	-5,904 Reduced 16.32%	30,276 $258,000
Q2 2022 Aug 05, 2022	BUY	$9.95 - $12.27 $25,790 - $31,803	2,592 Added 7.72%	36,180 $379,000
Q1 2022 May 13, 2022	BUY	$9.81 - $15.4 $51,993 - $81,620	5,300 Added 18.74%	33,588 $365,000
Q4 2021 Feb 15, 2022	BUY	$12.09 - $14.68 $173,999 - $211,274	14,392 Added 103.57%	28,288 $383,000
Q3 2021 Nov 15, 2021	BUY	$13.25 - $15.13 $184,122 - $210,246	13,896 New	13,896 $188,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Horizon Kinetics Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Horizon Kinetics Asset Management LLC with notifications on news.